Workflow
Hi-Tech Spring(301292)
icon
Search documents
海科新源(301292) - 第二届监事会第十四次会议决议公告
2025-07-04 11:15
证券代码:301292 证券简称:海科新源 公告编号:2025-036 山东海科新源材料科技股份有限公司 第二届监事会第十四次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或者重大遗漏。 一、监事会会议召开情况 山东海科新源材料科技股份有限公司第二届监事会第 十四次会议于2025年7月4日在公司会议室以现场结合通讯 方式召开。经全体监事一致同意,豁免本次会议通知期限。 会议应出席监事3人,实际出席的监事为3人,分别为李永、 张彬、李玲。出席会议人数符合《中华人民共和国公司法》 和《山东海科新源材料科技股份有限公司公司章程》(以下 简称"《公司章程》")规定。会议由监事会主席李永主持。 本次监事会的召开符合《中华人民共和国公司法》和《公 司章程》的规定,会议决议合法、有效。 二、监事会会议审议情况 经与会监事表决,审议通过该议案。 表决结果:3 票同意、0 票反对、0 票弃权,同意票数占 全体监事的 100%。 该议案尚需提交股东会审议。 (二)审议通过《关于公司接受关联方担保暨关联交易 的议案》 经审核,监事会认为:公司控股股东海科控股及关联方 海科瑞林为公 ...
海科新源(301292) - 第二届董事会第十九次会议决议公告
2025-07-04 11:15
证券代码:301292 证券简称:海科新源 公告编号:2025-035 山东海科新源材料科技股份有限公司 第二届董事会第十九次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、 完整,没有虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 山东海科新源材料科技股份有限公司董事会第二届董 事会第十九次会议于2025年7月4日在公司会议室以现场结 合通讯方式召开,经全体董事一致同意,豁免本次会议通知 期限。会议应出席董事9人,实际出席的董事9人,分别为杨 晓宏、张在忠、崔志强、马立军、吴雷雷、尉彬彬、王爱东、 孙新华、肖振宇,其中王爱东、孙新华、肖振宇以通讯方式 出席会议。出席会议人数符合《中华人民共和国公司法》和 《山东海科新源材料科技股份有限公司公司章程》(以下简 称"《公司章程》")规定。公司监事列席本次会议,会议 由公司董事长杨晓宏主持。 二、董事会会议审议情况 会议以投票方式表决,审议通过如下议案: 的议案》 为贯彻落实自 2024 年 7 月 1 日起实施的《公司法》,进 一步提高公司规范化运作水平,根据《上市公司章程指引》 等法律法规的规定,结合公司实际情况,公司拟对《山东海 ...
海科新源:双轮驱动破局 软硬兼修跨越周期
Core Viewpoint - The electrolyte industry is experiencing a reshuffle, with leading companies like Haike Xinyuan achieving record quarterly revenues despite the overall industry downturn [2][3]. Group 1: Company Performance - Haike Xinyuan is projected to achieve over 3.6 billion yuan in revenue in 2024, a year-on-year increase of over 7%, and surpassed 1.1 billion yuan in Q1 2025, with a growth rate exceeding 30% [2]. - The company holds a market share of over 40% in the global electrolyte solvent market, positioning itself as a leader [3]. - The company has established a comprehensive product matrix covering lithium battery electrolyte solvents and additives, with applications in major sectors like power batteries and energy storage systems [3]. Group 2: Industry Dynamics - The electrolyte industry is currently in a consolidation phase, with many players exiting due to price drops and intense competition since 2022 [3]. - Despite significant industry capacity, 80% of it has not formed a reliable supply, highlighting the stringent standards for automotive-grade products [3]. - The rapid iteration speed in the new energy sector necessitates that upstream suppliers keep pace with changes to ensure sustainable operations [3]. Group 3: Dual-Drive Strategy - The dual-drive strategy of new energy and consumer chemicals provides stable cash flow and market depth for Haike Xinyuan [4]. - The consumer chemicals segment, while growing at a slower pace than new energy, offers a broad market and stable demand, effectively hedging against industry volatility [5]. - The company has established production bases in Shandong, Jiangsu, and Hubei, optimizing resource allocation and reducing investment risks [5]. Group 4: Future Growth and Innovation - Haike Xinyuan is focusing on the second growth curve by increasing R&D efforts, particularly in solid-state battery technology [7]. - The company has a project pipeline of 34 initiatives, with 6 in the industrialization phase and 11 in the pilot testing stage [7]. - The company is committed to continuous innovation, with R&D investments exceeding 4% of revenue annually and a dedicated team of over 100 researchers [8]. Group 5: Market Expansion and Supply Chain - The company has established subsidiaries in Europe and the United States, enhancing its global market presence [5]. - Haike Xinyuan is leveraging partnerships with leading companies to optimize supply chain costs and maintain competitiveness in overseas markets [6]. - The company has developed a 48-hour supply network to ensure rapid delivery, primarily relying on domestic production and centralized shipping [5].
海科新源(301292) - 关于2025年员工持股计划实施进展的公告
2025-07-01 07:44
证券代码:301292 证券简称:海科新源 公告编号:2025-034 山东海科新源材料科技股份有限公司 关于2025年员工持股计划实施进展的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,不 存在虚假记载、误导性陈述或重大遗漏。 根据中国证监会《关于上市公司实施员工持股计划试点的指导意见》和深 圳证券交易所《深圳证券交易所上市公司自律监管指引第2号——创业板上市公 司规范运作》的相关规定,现将公司2025年员工持股计划实施进展情况公告如 下: 1、公司2025年员工持股计划已在中国证券登记结算有限责任公司开立证券 交易账户,账户名称:山东海科新源材料科技股份有限公司-2025年员工持股计 划,证券账户号码:0899481068。 2、截至2025年7月1日,公司2025年员工持股计划尚未购买公司股票。 公司将根据2025年员工持股计划的实施进展情况,按照相关法律法规的规 定及时履行信息披露义务。敬请广大投资者注意投资风险。 特此公告。 山东海科新源材料科技股份有限公司 董事会 2025年7月1日 山东海科新源材料科技股份有限公司(以下简称"公司")于2025年5月19 日、2025年6月4日 ...
海科新源(301292) - 关于对外担保的进展公告
2025-06-26 08:02
证券代码:301292 证券简称:海科新源 公告编号:2025-033 山东海科新源材料科技股份有限公司 关于对外担保的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确 和完整,没有虚假记载、误导性陈述或者重大遗漏。 一、担保情况概述 山东海科新源材料科技股份有限公司(以下简称"公司 ")分别于2025年4月23日、2025年5月15日召开第二届董事会 第十七次会议、2024年年度股东会审议通过了《关于公司及 子公司2025年度对外担保额度预计的议案》,同意公司及子 公司拟为2025年度合并报表范围内的子公司向金融机构及类 金融企业申请融资业务提供担保,预计担保金额不超过 45.00 亿元人民币,具体如下: | 序号 | 担保人 | 被担保人名称 | 担保人持股比例 | 2025年担保额度预计 | | --- | --- | --- | --- | --- | | | 名称 | | | (万元) | | 1 | | 江苏思派新能源科 技有限公司 | 100.00% | 180,000.00 | | 2 | | 海科新源材料科技 | 100.00% | 120,000.00 | | | 海科新 | ...
【私募调研记录】玄元投资调研海科新源
Zheng Quan Zhi Xing· 2025-06-26 00:07
Group 1 - The core viewpoint of the news is that XuanYuan Investment has conducted research on Haike Xinyuan, focusing on its solid-state battery electrolyte material development and international market expansion [1] - Haike Xinyuan's solid-state battery electrolyte material research has entered the laboratory stage, but the specific industrialization process requires comprehensive evaluation [1] - The company aims to enhance its overseas high-end product sales and significantly improve its operating conditions by optimizing product supply structure, customer structure, and raw material supply strategies by Q1 2025 [1] Group 2 - In 2024, Haike Xinyuan plans to allocate 152 million yuan for R&D, which accounts for 4.22% of its revenue, and has accumulated 128 patents [1] - The company will focus on research and development of lithium battery materials and consumer chemicals through technological innovation and multi-base layout to enhance product competitiveness [1]
海科新源(301292) - 301292海科新源投资者关系管理信息20250625
2025-06-25 08:50
Group 1: Company Strategy and Market Position - The company focuses on solid-state electrolytes and sodium-ion battery materials, with ongoing research and expected commercialization based on technology maturity and market demand [2][3] - Products have entered global supply chains, including Tesla and CATL, with plans for international market expansion and strategic layout in the U.S. [3] - The dual-driven model of "lithium battery materials + consumer chemicals" aims to enhance core competitiveness and operational efficiency [3] Group 2: Financial Performance - In Q1 2025, the company reported a revenue increase from 859 million CNY to 1.127 billion CNY, a year-on-year growth of 31.27%, marking a historical high for quarterly revenue [3] - The company achieved an 82% reduction in losses compared to the previous year, attributed to increased demand and optimized supply structures [3] Group 3: Research and Development - In 2024, R&D expenses amounted to 152 million CNY, representing 4.22% of revenue, with 128 patents obtained [4] - The company has established two major R&D platforms and focuses on developing high-performance lithium battery materials and green consumer chemicals [4] - Future R&D will prioritize high energy density, long cycle life, and environmentally friendly products to maintain competitive advantage [4]
38只创业板股获杠杆资金加仓超10%
Summary of Key Points Core Viewpoint - The latest financing balance of the ChiNext market reached 347.28 billion yuan, with a week-on-week increase of 2.19 billion yuan, indicating a positive trend in market financing activity [1]. Financing Balance Overview - The total margin balance for ChiNext stocks on June 24 was 348.22 billion yuan, an increase of 2.23 billion yuan from the previous trading day [1]. - Among the 496 stocks with increased financing balances, 38 stocks saw an increase of over 10% [1]. - The stock with the highest increase in financing balance was Boshuo Technology, which rose by 37.04% to a balance of 122.38 million yuan [3]. Stock Performance - On June 24, the ChiNext index rose by 2.30%, with an average increase of 4.35% for stocks with financing balance increases over 10% [1]. - Notable performers included Jiangsu Leili, Haitai Technology, and Hanwei Technology, with increases of 17.23%, 14.56%, and 13.49% respectively [1]. Major Inflows and Outflows - Among the stocks with significant financing balance increases, 28 stocks experienced net inflows of main funds, with Jiangsu Leili leading at 229 million yuan [2]. - Conversely, 10 stocks saw net outflows, with Wavelength Optoelectronics experiencing the largest outflow of 195 million yuan [2]. Stocks with Decreased Financing Balances - A total of 437 stocks experienced a decrease in financing balance, with 16 stocks seeing a decline of over 10% [4]. - The stock with the largest decrease was Senhe Co., with a financing balance drop of 43.89% to 52.37 million yuan [4]. Detailed Stock Data - Stocks with significant increases in financing balance included: - Boshuo Technology: 122.39 million yuan, +37.04%, closing at 34.35 yuan, +10.41% [3]. - Haike New Source: 122.31 million yuan, +35.04%, closing at 25.57 yuan, -4.16% [3]. - Stocks with significant decreases in financing balance included: - Senhe Co.: 52.37 million yuan, -43.89%, closing at 9.50 yuan, +0.85% [4]. - Huali Group: 82.84 million yuan, -35.89%, closing at 51.19 yuan, +2.75% [4].
29只创业板股获杠杆资金加仓超10%
Core Viewpoint - The latest financing balance of the ChiNext market is 345.083 billion yuan, with a week-on-week increase of 1.041 billion yuan, indicating a positive trend in market financing activity [1] Financing Balance Overview - As of June 23, the total margin balance of ChiNext stocks reached 345.991 billion yuan, an increase of 1.056 billion yuan from the previous trading day [1] - The financing balance specifically amounted to 345.083 billion yuan, reflecting a week-on-week increase of 1.041 billion yuan, while the securities lending balance was 90.9 million yuan, up by 15.5516 million yuan [1] Stocks with Increased Financing Balance - A total of 491 ChiNext stocks saw an increase in financing balance, with 29 stocks experiencing a growth rate exceeding 10% [1] - The stock with the highest increase in financing balance was Haike Xinyuan, which reached 90.5702 million yuan, marking a 76.65% increase from the previous day [1][3] - Other notable stocks with significant increases include C Xinhenghui (67.06%) and Sifang Jingchuang (30.21%) [1][3] Market Performance of Stocks - Among the stocks with a financing balance increase of over 10%, the average increase in stock price was 3.60%, with 23 stocks rising and one stock, Yihua New Material, hitting the daily limit [1] - The top gainers included Sifang Jingchuang (19.97%), Haike Xinyuan (13.44%), and Xinjin Power (13.05%) [1] Stocks with Decreased Financing Balance - A total of 443 stocks experienced a decrease in financing balance, with 25 stocks showing a decline of over 5% [4] - The stock with the largest decrease was Hengyu Xintong, with a financing balance of 15.2729 million yuan, down by 22.88% [4][5] - Other significant declines were observed in Zhejiang Huayuan (21.37%) and Tongling Co., Ltd. (18.77%) [4][5] Stocks with Notable Financing Balance Changes - A detailed table lists stocks with increased and decreased financing balances, highlighting their respective changes in financing balance, closing prices, and daily price fluctuations [3][4][5]
海科新源: 股票交易异常波动公告
Zheng Quan Zhi Xing· 2025-06-20 09:29
Group 1 - The company, Shandong Haike New Source Material Technology Co., Ltd., experienced a significant stock price fluctuation, with a cumulative increase of over 30% in closing prices over two consecutive trading days from June 19 to June 20, 2025 [1] - The company's board of directors conducted an inquiry regarding the stock price volatility and confirmed that there are no undisclosed significant information or major matters in the planning stage that could impact the stock [1][1] - The board also stated that there are no undisclosed matters that should be reported according to the Shenzhen Stock Exchange's rules, and previous disclosures do not require any corrections or supplements [1][1]